3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
22
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasm Metastasis
2
Metastatic Hormone-sensitive Prostate Cancer
2
Non-metastatic, Hormone naïve Prostate Cancer
1
Metastatic Hormone Sensitive Prostate Cancer
1
Metastatic Castration Resistant Prostate Cancer
1
Hormone Sensitive Prostate Cancer
1
Adenocarcinoma of the Prostate
1
Interventions
luprolide acetate gel depot
2
Leuprolide
2
Goserelin
2
radium Ra 223 dichloride
1
niraparib
1
apalutamide
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Watchful Waiting
1
Triptorelin Pamoate
1
Receptors, Bombesin
1
Radiotherapy
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Radiation
1
Observation
1
Neoadjuvant Therapy
1
Methods
1
Magnetic Resonance Spectroscopy
1
Gallium
1
Educational Status
1
Early Intervention, Educational
1
Counseling
1
Cholecalciferol
1
BAY 86-7548
1
Adjuvants, Pharmaceutic
1
68Ga-bombesin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Prostate Adenocarcinoma
×
Androgen Antagonists
×
Clear all
No trials found.